Related references
Note: Only part of the references are listed.Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma
Sriram Gubbi et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety
Sanjana Ballal et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Peptide Receptor Radionuclide Therapy Using Ac-225-DOTATOC Achieves Partial Remission in a Patient With Progressive Neuroendocrine Liver Metastases After Repeated beta-Emitter Peptide Receptor Radionuclide Therapy
Jingjing Zhang et al.
CLINICAL NUCLEAR MEDICINE (2020)
Radiation-related thyroid autoimmunity and dysfunction
Yuji Nagayama
JOURNAL OF RADIATION RESEARCH (2018)
Pattern of radiation-induced thyroid gland changes in nasopharyngeal carcinoma patients in 48 months after radiotherapy
Zhixiong Lin et al.
PLOS ONE (2018)
Painful Radiation Thyroiditis after 131I Therapy for Graves' Hyperthyroidism: Clinical Features and Ultrasonographic Findings in Five Cases
Tetsuya Mizokami et al.
EUROPEAN THYROID JOURNAL (2016)
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
John J. Zaknun et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Share Paper
